Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA cut its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 20.3% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 13,811 shares of the pharmacy operator’s stock after selling 3,525 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in Walgreens Boots Alliance were worth $361,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in the stock. New York Life Investment Management LLC increased its holdings in shares of Walgreens Boots Alliance by 0.4% during the third quarter. New York Life Investment Management LLC now owns 114,506 shares of the pharmacy operator’s stock valued at $2,547,000 after purchasing an additional 499 shares during the period. Fulton Bank N.A. increased its holdings in shares of Walgreens Boots Alliance by 0.5% during the fourth quarter. Fulton Bank N.A. now owns 107,071 shares of the pharmacy operator’s stock valued at $2,796,000 after purchasing an additional 523 shares during the period. Insight Folios Inc increased its holdings in shares of Walgreens Boots Alliance by 5.8% during the fourth quarter. Insight Folios Inc now owns 9,640 shares of the pharmacy operator’s stock valued at $252,000 after purchasing an additional 525 shares during the period. Moisand Fitzgerald Tamayo LLC increased its holdings in shares of Walgreens Boots Alliance by 29.6% during the third quarter. Moisand Fitzgerald Tamayo LLC now owns 2,333 shares of the pharmacy operator’s stock valued at $52,000 after purchasing an additional 533 shares during the period. Finally, Pinnacle Financial Partners Inc increased its holdings in shares of Walgreens Boots Alliance by 4.9% during the fourth quarter. Pinnacle Financial Partners Inc now owns 11,866 shares of the pharmacy operator’s stock valued at $310,000 after purchasing an additional 555 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Stock Down 0.3 %

Walgreens Boots Alliance stock traded down $0.05 during mid-day trading on Tuesday, hitting $18.17. The company’s stock had a trading volume of 4,062,051 shares, compared to its average volume of 13,986,867. Walgreens Boots Alliance, Inc. has a 52-week low of $17.51 and a 52-week high of $35.54. The firm’s 50 day moving average is $20.33 and its 200 day moving average is $21.89. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32. The company has a market cap of $15.68 billion, a PE ratio of -2.60, a price-to-earnings-growth ratio of 1.13 and a beta of 0.73.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The company had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. During the same period last year, the business earned $1.16 EPS. The business’s quarterly revenue was up 6.3% on a year-over-year basis. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Insider Transactions at Walgreens Boots Alliance

In other news, Director Valerie B. Jarrett purchased 4,456 shares of the business’s stock in a transaction dated Monday, January 29th. The stock was bought at an average cost of $22.44 per share, with a total value of $99,992.64. Following the purchase, the director now directly owns 4,456 shares of the company’s stock, valued at $99,992.64. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, CFO Manmohan Mahajan acquired 6,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were acquired at an average cost of $19.38 per share, with a total value of $116,280.00. Following the purchase, the chief financial officer now owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Valerie B. Jarrett acquired 4,456 shares of the business’s stock in a transaction that occurred on Monday, January 29th. The stock was bought at an average cost of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the purchase, the director now directly owns 4,456 shares in the company, valued at approximately $99,992.64. The disclosure for this purchase can be found here. Insiders bought 13,456 shares of company stock valued at $270,423 in the last three months. Corporate insiders own 17.40% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Bank of America lowered their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a report on Tuesday, March 26th. Truist Financial reaffirmed a “hold” rating and set a $25.00 target price on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. HSBC reaffirmed a “reduce” rating and set a $20.00 target price (down previously from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. Morgan Stanley decreased their target price on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a research note on Monday, April 1st. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research note on Wednesday, April 3rd. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus target price of $24.36.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.